MBX Biosciences (NASDAQ: MBX) net income
MBX Biosciences reported a net loss of $87.0m for fiscal 2025; in fiscal 2024 it reported a net loss of $61.9m. Earnings per share were −$2.38.
MBX Biosciences's best year of the last 3 was fiscal 2023. It reported a loss in 3 of those 3 years.
Embed this chart
Copy this code into your website or blog. The chart updates with each new annual report.
Net income by fiscal year
| Fiscal year | Net income | Change | Net margin | Earnings per share |
|---|---|---|---|---|
| 2025 | −$87.0m | — | — | −$2.38 |
| 2024 | −$61.9m | — | — | −$5.82 |
| 2023 | −$32.6m | — | — | −$31.96 |
The change compares each fiscal year with the one before and is not calculated when the previous year closed with a loss. Net margin is net income over revenue from the same filing. Figures are in millions of US dollars, except per-share amounts.
MBX Biosciences net income compared with its sector
By net income for its latest fiscal year, MBX Biosciences ranks 325th of the 501 US health care companies with a page on Celsmar.
| Rank | Company | Net income | Net margin |
|---|---|---|---|
| 323rd | Artiva Biotherapeutics | −$83.9m | — |
| 324th | Clover Health Investments | −$85.5m | −4.4% |
| 325th | MBX Biosciences | −$87.0m | — |
| 326th | Altimmune | −$88.1m | −214,861.0% |
| 327th | Neurogene | −$90.4m | — |
Each amount is in the currency the company reports in; the rank converts them to US dollars at the 16 November 2026 exchange rate. The rest are in US health care stocks.
Questions about the net income of MBX Biosciences
- How much did MBX Biosciences earn in fiscal 2025?
- MBX Biosciences reported a net loss of $87.0m for fiscal 2025. In fiscal 2024 it reported a net loss of $61.9m.
- What are the earnings per share of MBX Biosciences?
- They were −$2.38 in fiscal 2025, compared with −$5.82 in fiscal 2024.
- Where does MBX Biosciences rank in its sector by net income?
- It ranks 325th of the 501 US health care companies with a page on Celsmar, by net income for its latest fiscal year.
- Where do the figures for MBX Biosciences come from?
- From the annual report (Form 10-K) that MBX Biosciences files with the SEC, the US securities regulator. Each fiscal year links to its filing.
Where each figure comes from
From the annual report (Form 10-K) that MBX Biosciences files with the SEC. The filing for each fiscal year: 2025 · 2024 · 2023. More on MBX Biosciences: the MBX Biosciences page · annual accounts · insider transactions.
Information prepared from the accounts the company files with the regulator, for information purposes only. It is not financial advice or a recommendation to buy or sell. Updated on 12 November 2026.